Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$95.95 /

+1.195 (+1.26%)

, ACN

Accenture

$212.08 /

-0.48 (-0.23%)

04:55
02/12/20
02/12
04:55
02/12/20
04:55

Drug Information Association to hold a forum

Regulatory Submissions, Information & Document Management Forum will be held in North Bethesda, MD on February 10-12.

ABBV

AbbVie

$95.95 /

+1.195 (+1.26%)

ACN

Accenture

$212.08 /

-0.48 (-0.23%)

AGN

Allergan

$200.99 /

+1.36 (+0.68%)

ALNY

Alnylam

$129.51 /

-2.03 (-1.54%)

ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

AMZN

Amazon.com

$2,152.45 /

+18.53 (+0.87%)

ATRA

Atara Biotherapeutics

$14.34 /

-0.04 (-0.28%)

BHC

Bausch Health

$28.18 /

-0.01 (-0.04%)

BIIB

Biogen

$331.87 /

-7.06 (-2.08%)

BMY

Bristol-Myers

$67.00 /

+0.075 (+0.11%)

CAH

Cardinal Health

$59.42 /

+0.25 (+0.42%)

ESALY

Eisai

$0.00 /

+ (+0.00%)

GOOGL

Alphabet Class A

$1,509.32 /

+1.62 (+0.11%)

IQV

Iqvia

$161.50 /

+1.59 (+0.99%)

LLY

Eli Lilly

$144.24 /

-1.29 (-0.89%)

LXRX

Lexicon

$3.23 /

+0.14 (+4.53%)

MRK

Merck

$85.26 /

-0.41 (-0.48%)

PFE

Pfizer

$38.09 /

+0.27 (+0.71%)

REGN

Regeneron

$396.76 /

+9.56 (+2.47%)

TEVA

Teva

$12.32 /

-0.03 (-0.24%)

VRTX

Vertex

$247.82 /

+3.06 (+1.25%)

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 14

    Feb

  • 18

    Feb

  • 19

    Feb

  • 24

    Feb

  • 24

    Feb

  • 25

    Feb

  • 26

    Feb

  • 02

    Mar

  • 06

    Mar

  • 09

    Mar

  • 10

    Mar

  • 10

    Mar

  • 13

    Mar

  • 14

    Mar

  • 17

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 06

    Apr

  • 23

    Apr

  • 28

    Apr

  • 15

    May

  • 26

    May

  • 04

    Jun

ABBV AbbVie
$95.95 /

+1.195 (+1.26%)

02/11/20 SunTrust
Allergan price target raised to $202 from $194 at SunTrust
02/10/20 Mizuho
AbbVie price target raised to $104 from $96 at Mizuho
02/07/20 Piper Sandler
AbbVie price target raised to $97 from $95 at Piper Sandler
02/05/20 Mizuho
AbbVie initiated with a Buy at Mizuho
ACN Accenture
$212.08 /

-0.48 (-0.23%)

01/21/20 Berenberg
Accenture initiated with a Buy at Berenberg
01/09/20 Wells Fargo
Accenture price target raised to $230 from $225 at Wells Fargo
01/07/20
Fly Intel: Top five analyst downgrades
01/07/20 MoffettNathanson
Accenture downgraded to Neutral from Buy at MoffettNathanson
AGN Allergan
$200.99 /

+1.36 (+0.68%)

02/03/20 Oppenheimer
Eyenovia downgraded to Perform from Outperform at Oppenheimer
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
01/22/20 Wells Fargo
Allergan downgraded to Equal Weight from Overweight at Wells Fargo
ALNY Alnylam
$129.51 /

-2.03 (-1.54%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
12/05/19 JPMorgan
Audentes Therapeutics downgraded to Neutral from Overweight at JPMorgan
12/03/19 Raymond James
Audentes downgraded to Market Perform from Outperform at Raymond James
12/03/19 H.C. Wainwright
Audentes Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
AMZN Amazon.com
$2,152.45 /

+18.53 (+0.87%)

02/11/20 Pivotal Research
Pivotal downgrades Facebook to Sell with $180 target on increasing concerns
02/07/20 BWS Financial
BWS downgrades Netgear on pricing pressure from Google, Amazon
02/07/20 Needham
Needham sees 'best case' where Amazon buys WWE, cuts target to $55 in meantime
02/03/20 Bernstein
Amazon Q4 results beat even bullish expectations, says Bernstein
ATRA Atara Biotherapeutics
$14.34 /

-0.04 (-0.28%)

11/08/19 JPMorgan
Atara Biotherapeutics downgraded to on lack of catalysts at JPMorgan
11/08/19 JPMorgan
Atara Biotherapeutics downgraded to Neutral from Overweight at JPMorgan
10/25/19 Stifel
Stifel recommend buying into weakness on Atara Biotherapeutics CSO resignation
10/25/19 Mizuho
Mizuho says CSO Chris Haqq to remain on as Atara adviser
BHC Bausch Health
$28.18 /

-0.01 (-0.04%)

01/29/20 Wolfe Research
Bausch Health downgraded to Peer Perform from Outperform at Wolfe Research
01/22/20 Wells Fargo
Bausch Health upgraded to Equal Weight from Underweight at Wells Fargo
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
BIIB Biogen
$331.87 /

-7.06 (-2.08%)

02/10/20 William Blair
William Blair sees little change to sentiment for aducanumab after DIAN-TU fails
02/07/20 Oppenheimer
Biogen price target raised to $390 from $338 at Oppenheimer
02/07/20 Nomura Instinet
Biogen price target raised to $392 from $320 at Nomura Instinet
02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
BMY Bristol-Myers
$67.00 /

+0.075 (+0.11%)

01/31/20 JPMorgan
Agios Pharmaceuticals could see volatility after Idhifa news, says JPMorgan
01/10/20 Goldman Sachs
Goldman keeps Sell on Nektar despite amended Bristol-Myers Squibb agreement
01/10/20 Piper Sandler
Nektar update with Bristol-Myers 'positive all around,' says Piper Sandler
01/10/20 H.C. Wainwright
Amended Nektar, Bristol pact reflects bempeg limitations, says H.C. Wainwright
CAH Cardinal Health
$59.42 /

+0.25 (+0.42%)

02/07/20 Baird
Cardinal Health upgraded to Outperform at Baird
02/07/20 Mizuho
Cardinal Health price target raised to $58 from $52 at Mizuho
02/07/20 Baird
Cardinal Health upgraded to Outperform from Neutral at Baird
12/16/19
Fly Intel: Top five analyst downgrades
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
GOOGL Alphabet Class A
$1,509.32 /

+1.62 (+0.11%)

02/07/20 Citi
Alphabet price target raised to $1,700 from $1,500 at Citi
02/05/20 Argus
Alphabet price target raised to $1,620 from $1,450 at Argus
IQV Iqvia
$161.50 /

+1.59 (+0.99%)

01/13/20 Morgan Stanley
Veeva upgraded to Overweight following underperformance at Morgan Stanley
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Iqvia initiated with an Overweight at Wells Fargo
01/06/20 Citi
Iqvia initiated with a Buy at Citi
LLY Eli Lilly
$144.24 /

-1.29 (-0.89%)

02/05/20 Mizuho
Eli Lilly initiated with a Neutral at Mizuho
02/05/20 Mizuho
Eli Lilly initiated with a Neutral at Mizuho
01/23/20 H.C. Wainwright
Dermira downgraded to Neutral from Buy at H.C. Wainwright
LXRX Lexicon
$3.23 /

+0.14 (+4.53%)

12/20/19 Stifel
Stifel says Lexicon 'missed opportunity' with sotagliflozin data
12/11/19 Gabelli
Lexicon downgraded to Hold on valuation at Gabelli
12/11/19 Gabelli
Lexicon downgraded to Hold from Buy at Gabelli
11/08/19 Citi
Lexicon downgraded to Neutral from Buy at Citi
MRK Merck
$85.26 /

-0.41 (-0.48%)

02/06/20 RBC Capital
Merck price target lowered to $92 from $99 at RBC Capital
02/06/20 Maxim
Armata Pharmaceuticals initiated with a Buy at Maxim
01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
PFE Pfizer
$38.09 /

+0.27 (+0.71%)

02/11/20 Roth Capital
GlycoMimetics termination notice from Pfizer no surprise, says Roth Capital
02/06/20 Mizuho
Pfizer initiated with a Buy, $42 price target at Mizuho
02/05/20 Mizuho
Pfizer initiated with a Buy at Mizuho
01/29/20 Cantor Fitzgerald
Pfizer growth prospect concerns overblown, says Cantor Fitzgerald
REGN Regeneron
$396.76 /

+9.56 (+2.47%)

02/11/20 Argus
Regeneron upgraded to Buy from Hold at Argus
02/11/20 Argus
Regeneron upgraded to Buy from Hold at Argus
02/07/20 SunTrust
Regeneron price target raised to $400 from $360 at SunTrust
02/06/20 Piper Sandler
Regeneron's early strength 'appropriate' after earnings, says Piper Sandler
TEVA Teva
$12.32 /

-0.03 (-0.24%)

02/10/20 Stifel
Corcept received 'clear win' with favorable PTAB decision on Korlym, says Stifel
11/27/19 Gabelli
Teva shares should be bought on opioid suit headline weakness, says Gabelli
11/20/19 Jefferies
Teva 'offered little' on progress toward opioids settlement, says Jefferies
VRTX Vertex
$247.82 /

+3.06 (+1.25%)

01/31/20 Baird
Baird cuts Vertex to Neutral on valuation after Trikafta 'smokes expectations'
01/31/20 RBC Capital
Vertex price target raised to $260 from $240 at RBC Capital
01/31/20 SunTrust
Vertex price target raised to $285 from $235 at SunTrust
01/31/20 JPMorgan
Vertex price target raised to $260 from $247 at JPMorgan

TODAY'S FREE FLY STORIES

Downgrade
Pinduoduo downgraded to Neutral from Buy at Goldman Sachs » 19:23
05/24/20
05/24
19:23
05/24/20
19:23
PDD

Pinduoduo

$68.72 /

+8.68 (+14.46%)

Goldman Sachs analyst…

Goldman Sachs analyst Piyush Mubayi downgraded Pinduoduo to Neutral from Buy with a price target of $62.70, up from $54. The stock closed Friday up $8.70 to $68.70. After rallying 239% in the past year, shares of Pinduoduo reflect its "unique value proposition" to online shoppers in China, Mubayi tells investors in a research note. The analyst remains positive on the company's longer-term earnings growth outlook and believes it remains well positioned to capture the "continuous rising tide" in e-commerce post COVID-19. However, Mubayi sees "limited valuation attraction" at current share levels.

ShowHide Related Items >><<
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

05/22/20 CLSA
Pinduoduo price target raised to $72 from $46.50 at CLSA
05/20/20 BofA
Pinduoduo downgraded to Neutral from Buy at BofA
04/29/20 KeyBanc
Pinduoduo price target raised to $65 from $50 at KeyBanc
04/20/20 Credit Suisse
Pinduoduo upgraded to Outperform from Neutral at Credit Suisse
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

Hot Stocks
iQIYI launches S-diamond Membership package » 16:10
05/24/20
05/24
16:10
05/24/20
16:10
IQ

iQIYI

$15.50 /

-1.01 (-6.12%)

iQIYI launched its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

05/20/20 HSBC
iQIYI price target lowered to $23 from $32 at HSBC
04/14/20
Fly Intel: Top five analyst initiations
04/13/20 Oppenheimer
iQIYI initiated with an Outperform at Oppenheimer
04/09/20 Mizuho
Baidu concerns overstated, current valuation 'compelling,' says Mizuho
IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

Hot Stocks
Unit Corp. files Chapter 11 bankruptcy to restructure balance sheet » 16:04
05/24/20
05/24
16:04
05/24/20
16:04
UNT

Unit Corp.

$0.23 /

-0.0203 (-8.02%)

Unit Corp. announced that…

Unit Corp. announced that it has filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division to effectuate a pre-negotiated Chapter 11 plan of reorganization that will reduce the company's funded debt obligations by more than $650M and right-size the company's balance sheet for go-forward operations. The company expects to continue to operate in the ordinary course throughout the Chapter 11 process without material disruption to its vendors, customers, or partners. Importantly, the company's 50%-owned midstream affiliate, Superior Pipeline company and its subsidiaries, is not a debtor in the Chapter 11 cases and is unaffected by the company's Chapter 11 filing. Additionally, the company does not anticipate that payments to vendors and suppliers of its subsidiary Unit Drilling company will be impacted. The Chapter 11 petitions were filed in accordance with a Restructuring Support Agreement between the company, the holders of more than 70% of the company's 6.625% senior subordinated notes due 2021 and all of the lenders under the company's Senior Credit Agreement. The RSA sets forth the principal terms of the restructuring transaction that will be effectuated by the Plan, including an equitization of all of the outstanding Subordinated Notes and the replacement of the existing RBL facility and the DIP financing with a $180M exit financing facility. Consummation of the Plan will be subject to confirmation by the Court and other conditions in the Plan, the RSA and related transaction documents. With the filing, and subject to court approval, the company has received a commitment from the RBL Lenders that are parties to the RSA to provide up to $36M in debtor-in-possession financing. The company anticipates up to $18M will be available on an interim basis. This financing, combined with the company's usual operating cash flows, is expected to provide sufficient liquidity for the company to continue to operate in the ordinary course through the restructuring process. The company has filed several customary motions with the court seeking authorization to support its operations while this process is ongoing, including authority to continue payment of employee wages, salaries and benefits without interruption, and to continue paying all vendors and suppliers of Unit Drilling Company in the ordinary course of business. The company expects to receive court approval for these requests.

ShowHide Related Items >><<
UNT Unit Corp.
$0.23 /

-0.0203 (-8.02%)

UNT Unit Corp.
$0.23 /

-0.0203 (-8.02%)

03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Unit Corp. downgraded to Underweight from Equal Weight at Stephens
01/06/20 Raymond James
Unit Corp. downgraded at Raymond James on commodity price weakness
01/06/20 Raymond James
Unit Corp. downgraded to Underperform from Market Perform at Raymond James
UNT Unit Corp.
$0.23 /

-0.0203 (-8.02%)

Recommendations
Political risks could cap Alibaba valuation near term, says Stifel » 13:04
05/24/20
05/24
13:04
05/24/20
13:04
BABA

Alibaba

$199.58 /

-12.42 (-5.86%)

Alibaba Group Holding on…

Alibaba Group Holding on Friday reported stronger than expected fiscal Q4 results with revenue up 22% year-over-year, Stifel analyst Scott Devitt tells investors in a research note. Further, quarter to date trends have demonstrated a "healthy rebound" from the pandemic as lockdowns have eased, adds the analyst. Devitt keeps a Buy rating on Alibaba shares with a $230 price target. The stock closed Friday down 6% to $199.70. The company guided fiscal 2021 revenue growth to 28%, in line with expectations, but management noted continuing uncertainty stemming from COVID-19 and pointed to U.S., China tensions adding additional uncertainty beyond the pandemic, says the analyst. Devitt believes political risks are heightened and could limit Alibaba's valuation multiple in the near-term.

ShowHide Related Items >><<
BABA Alibaba
$199.58 /

-12.42 (-5.86%)

BABA Alibaba
$199.58 /

-12.42 (-5.86%)

05/22/20 Baird
Baird 'opportunistic buyers' of Alibaba shares after earnings
05/22/20 Goldman Sachs
Goldman Sachs keeps Buy rating on Alibaba after better than expected Q4
04/09/20 Morgan Stanley
Alibaba 'core of core' revenue recovery outlook improved, says Morgan Stanley
03/23/20 Oppenheimer
Tencent, Baidu, Alibaba attractive at current levels, says Oppenheimer
BABA Alibaba
$199.58 /

-12.42 (-5.86%)

BABA Alibaba
$199.58 /

-12.42 (-5.86%)

BABA Alibaba
$199.58 /

-12.42 (-5.86%)

BABA Alibaba
$199.58 /

-12.42 (-5.86%)

Hot Stocks
Hertz files for bankruptcy after 'sudden and dramatic' COVID-19 impact » 12:55
05/24/20
05/24
12:55
05/24/20
12:55
HTZ

Hertz

$2.84 /

-0.215 (-7.04%)

Hertz Global Holdings…

Hertz Global Holdings announced late Friday that it and certain of its U.S. and Canadian subsidiaries have filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. "The impact of COVID-19 on travel demand was sudden and dramatic, causing an abrupt decline in the Company's revenue and future bookings. Hertz took immediate actions to prioritize the health and safety of employees and customers, eliminate all non-essential spending and preserve liquidity. However, uncertainty remains as to when revenue will return and when the used-car market will fully re-open for sales, which necessitated today's action. The financial reorganization will provide Hertz a path toward a more robust financial structure that best positions the Company for the future as it navigates what could be a prolonged travel and overall global economic recovery," the company said in a statement. Hertz's principal international operating regions including Europe, Australia and New Zealand are not included in the U.S. Chapter 11 proceedings. In addition, Hertz's franchised locations, which are not owned by the company, also are not included in the Chapter 11 proceedings. All of Hertz's businesses globally, including its Hertz, Dollar, Thrifty, Firefly, Hertz Car Sales, and Donlen subsidiaries, are open and serving customers. All reservations, promotional offers, vouchers, and customer and loyalty programs, including rewards points, are expected to continue as usual. As of the filing date, Hertz had more than $1B in cash on hand to support its ongoing operations. "Depending upon the length of the COVID-19 induced crisis and its impact on revenue, the Company may seek access to additional cash, including through new borrowings, as the reorganization progresses," it added. Hertz said that while it negotiated short-term relief with such creditors, it was unable to secure longer-term agreements. The stock in after-hours trading decline 36%, or $1.02, to $1.82.

ShowHide Related Items >><<
HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

HTZ Hertz
$2.84 /

-0.215 (-7.04%)

Recommendations
Marston's price target raised to 50 GBp from 35 GBp at Jefferies » 12:48
05/24/20
05/24
12:48
05/24/20
12:48
MARZF

Marston's

$0.00 /

+ (+0.00%)

Jefferies analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MARZF Marston's
$0.00 /

+ (+0.00%)

04/30/20 JPMorgan
Marston's price target lowered to 57 GBp from 128 GBp at JPMorgan
04/21/20 Jefferies
Marston's price target lowered to 35 GBp from 90 GBp at Jefferies
On The Fly
Opening Day: SelectQuote goes public amid COVID-19, raises $360M in IPO » 08:45
05/24/20
05/24
08:45
05/24/20
08:45
SLQT

SelectQuote

$26.74 /

-0.15 (-0.56%)

, NARI

Inari Medical

$42.47 /

+ (+0.00%)

, FOUR

Four Media Company

$0.00 /

+ (+0.00%)

, LYRA

Lyra Therapeutics

$14.53 /

-0.4 (-2.68%)

, AYLA

Ayala Pharmaceuticals

$15.52 /

+0.5 (+3.33%)

, ADCT

ADC Therapeutics

$35.10 /

+1.17 (+3.45%)

Insurance comparison…

Open Full Text

ShowHide Related Items >><<
    Hot Stocks
    PG&E announces voting results, plan of reorganization accepted by victims » 14:31
    05/23/20
    05/23
    14:31
    05/23/20
    14:31
    PCG

    PG&E

    $11.70 /

    -0.125 (-1.06%)

    PG&E announced the…

    PG&E announced the final voting results on PG&E Corp. and Pacific Gas and Electric Company's joint Chapter 11 Plan of Reorganization as certified by Prime Clerk, PG&E's court-authorized solicitation and balloting agent. The Plan received overwhelming support from all but one of the classes of impaired creditors and interest holders entitled to vote, including fire claimants, insurance subrogation claimants, public entity fire claimants, certain holders of prepetition funded debt and other creditors, and shareholders. The final voting results were filed with the U.S. Bankruptcy Court for the Northern District of California on May 22, 2020. The voting certification reflects that the Plan was accepted by in excess of 85 percent in both number and amount of wildfire victims who cast votes on the Plan. "The acceptance of the Plan of Reorganization by wildfire victims and other voting creditors and shareholders is an important milestone in our financial restructuring process, moving PG&E one step closer to compensating fire victims and emerging from Chapter 11 as a stronger, financially sound company positioned for long-term success," said Bill Johnson, CEO and President of PG&E. The final voting results help the company stay on track to get its Plan confirmed by June 30, 2020, the deadline under Assembly Bill 1054. The sole dissenting class consists of holders of prepetition securities law claims related to PG&E common stock; these claims are subordinated pursuant to the provisions of the Bankruptcy Code. The company's Plan confirmation hearing is scheduled for May 27, 2020.

    ShowHide Related Items >><<
    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    05/15/20 Barclays
    Barclays upgrades Utilities sector along with PG&E and two others
    05/15/20 Barclays
    PG&E upgraded to Overweight from Equal Weight at Barclays
    05/06/20 Mizuho
    PG&E price target raised to $13.50 from $12.50 at Mizuho
    05/04/20
    Fly Intel: Top five analyst upgrades
    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    PCG PG&E
    $11.70 /

    -0.125 (-1.06%)

    Periodicals
    Not every cloud stock has soared, DropBox worth a look, Barron's says » 12:22
    05/23/20
    05/23
    12:22
    05/23/20
    12:22
    DBX

    Dropbox

    $21.67 /

    -0.465 (-2.10%)

    DropBox (DBX), an early…

    DropBox (DBX), an early cloud player, remains well below all-time highs, even as the rest of the work -from-home universe has soared, Daren Fonda writes in this week's edition of Barron's. Dropbox stores photos, videos, and documents for some 600M users, and while storage is generally a background service and rarely top of mind, the company is now pushing its way into the foreground, the author notes. The goal is to be a neutral player where anyone can converse, exchange content, and collaborate, regardless of corporate origin or allegiance, Fonda adds. Reference Link

    ShowHide Related Items >><<
    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    05/15/20 Gordon Haskett
    Gordon Haskett points to possible signs of activism at Dropbox, McKesson
    05/15/20 Citi
    Dropbox initiated with a Buy at Citi
    05/08/20 Jefferies
    Dropbox price target raised to $22 from $20 at Jefferies
    03/26/20 Goldman Sachs
    Dropbox downgraded to Sell from Neutral at Goldman Sachs
    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    DBX Dropbox
    $21.67 /

    -0.465 (-2.10%)

    Periodicals
    Americans rushing to 'the great outdoors,' Barron's says » 11:44
    05/23/20
    05/23
    11:44
    05/23/20
    11:44
    YETI

    Yeti

    $30.41 /

    +0.38 (+1.27%)

    , POOL

    Pool Corp.

    $238.08 /

    -0.32 (-0.13%)

    , WGO

    Winnebago

    $58.06 /

    +0.47 (+0.82%)

    Americans began the…

    Americans began the lockdown by hoarding toilet paper, sweat pants, and puzzles, but now with Memorial Day around the corner, it's bicycles, boats, and inflatable pools, Alex Eule writes in this week's edition of Barron's. Investors have caught on to the outdoor boom. RV maker Winnebago Industries (WGO) has soared 61% in the last month, while shares of Pool Cor. (POOL), which makes supplies for pools, are up 29% over the past month, the author notes. And not every outdoor stock is sky-high, yet. Yeti (YETI) is still down 15% in 2020, the publication adds. Reference Link

    ShowHide Related Items >><<
    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    WGO Winnebago
    $58.06 /

    +0.47 (+0.82%)

    POOL Pool Corp.
    $238.08 /

    -0.32 (-0.13%)

    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    05/05/20 Piper Sandler
    Yeti price target lowered to $34 from $50 at Piper Sandler
    04/28/20 BTIG
    Yeti initiated with a Buy at BTIG
    04/17/20 Stifel
    Yeti downgraded to Hold from Buy at Stifel
    04/15/20
    Fly Intel: Top five analyst downgrades
    POOL Pool Corp.
    $238.08 /

    -0.32 (-0.13%)

    05/19/20 KeyBanc
    Pool Corp. price target raised to $250 from $225 at KeyBanc
    05/19/20 KeyBanc
    Pool Corp. price target raised to $250 from $225 at KeyBanc
    05/18/20 William Blair
    Pool Corp. remains 'favorite safety stock' at William Blair
    04/17/20 Sidoti
    Pool Corp. downgraded to Neutral from Buy at Sidoti
    WGO Winnebago
    $58.06 /

    +0.47 (+0.82%)

    05/12/20 SunTrust
    Winnebago price target raised to $60 from $45 at SunTrust
    04/17/20 Wolfe Research
    Winnebago initiated with a Peer Perform at Wolfe Research
    03/26/20 SunTrust
    Winnebago price target raised to $38 from $28 at SunTrust
    01/27/20 KeyBanc
    Winnebago initiated with an Overweight at KeyBanc
    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    WGO Winnebago
    $58.06 /

    +0.47 (+0.82%)

    POOL Pool Corp.
    $238.08 /

    -0.32 (-0.13%)

    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    WGO Winnebago
    $58.06 /

    +0.47 (+0.82%)

    YETI Yeti
    $30.41 /

    +0.38 (+1.27%)

    Periodicals
    Retail giants to keep gaining ground in post-COVID world, Barron's says » 11:30
    05/23/20
    05/23
    11:30
    05/23/20
    11:30
    WMT

    Walmart

    $124.32 /

    -0.64 (-0.51%)

    , AMZN

    Amazon.com

    $2,435.90 /

    -11.65 (-0.48%)

    The impact of COVID-19…

    The impact of COVID-19 hasn't been evenly felt among the nation's retailers, with the biggest and strongest not just surviving, but thriving, while many smaller store chains and mom-and-pop shops face disaster, Teresa Rivas writes in this week's edition of Barron's. In the past five years, the rise of e-commerce has changed the retail industry, tilting the landscape in favor of behemoths such as Amazon (AMZN) and Walmart (WMT) that can afford slick websites and fast, free delivery service, the author notes. Now, without a vaccine or effective treatment for coronavirus available near term, these well-capitalized companies are likely to keep gobbling up market share at the expense of smaller operators, Rivas contends. Reference Link

    ShowHide Related Items >><<
    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    05/21/20 Bernstein
    Walmart built for crisis, investing despite uncertainty, says Bernstein
    05/20/20 Credit Suisse
    Walmart price target raised to $135 from $127 at Credit Suisse
    05/20/20 Guggenheim
    Walmart price target raised to $140 from $135 at Guggenheim
    05/20/20 Deutsche Bank
    Walmart price target raised to $139 from $134 at Deutsche Bank
    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    05/18/20 Bernstein
    Amazon not building standalone overnight network, says Bernstein
    05/14/20 KeyBanc
    Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
    05/12/20 Barrington
    Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
    05/11/20 B. Riley FBR
    Amazon buyout may not appeal to AMC shareholders, says B. Riley FBR
    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    WMT Walmart
    $124.32 /

    -0.64 (-0.51%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    AMZN Amazon.com
    $2,435.90 /

    -11.65 (-0.48%)

    On The Fly
    Week in Review: How Trump's policies moved stocks » 09:55
    05/23/20
    05/23
    09:55
    05/23/20
    09:55
    AZN

    AstraZeneca

    $55.21 /

    -0.04 (-0.07%)

    , MRNA

    Moderna

    $69.00 /

    +1.99 (+2.97%)

    , JNJ

    Johnson & Johnson

    $144.37 /

    -0.29 (-0.20%)

    , SNY

    Sanofi

    $47.31 /

    -0.18 (-0.38%)

    , MRK

    Merck

    $76.37 /

    -0.17 (-0.22%)

    , MYL

    Mylan

    $15.63 /

    -0.37 (-2.31%)

    , TEVA

    Teva

    $11.97 /

    -0.05 (-0.42%)

    , NVS

    Novartis

    $84.84 /

    -0.12 (-0.14%)

    , BAYRY

    Bayer

    $0.00 /

    + (+0.00%)

    , LITE

    Lumentum

    $73.50 /

    +1.74 (+2.42%)

    , NPTN

    NeoPhotonics

    $8.31 /

    + (+0.00%)

    Catch up on the top…

    Open Full Text

    ShowHide Related Items >><<
    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    NPTN NeoPhotonics
    $8.31 /

    + (+0.00%)

    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    BAYRY Bayer
    $0.00 /

    + (+0.00%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    05/14/20 Evercore ISI
    Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
    05/06/20 Morgan Stanley
    AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
    05/04/20 Citi
    Citi opens 'positive catalyst watch' on AstraZeneca
    05/01/20 Guggenheim
    AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    05/20/20 Morgan Stanley
    Moderna price target raised to $90 from $37 at Morgan Stanley
    05/19/20 Piper Sandler
    Piper trims Moderna target to $100 on capital raise dilution
    05/19/20 BMO Capital
    Moderna price target raised to $112 from $83 at BMO Capital
    05/19/20 H.C. Wainwright
    BioNTech upgraded to Buy from Neutral at H.C. Wainwright
    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    05/12/20 Oppenheimer
    Novavax price target raised to $38.50 from $19 at Oppenheimer
    04/29/20 Stephens
    Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
    04/29/20 Barclays
    Johnson & Johnson price target raised to $182 from $173 at Barclays
    04/28/20 UBS
    Johnson & Johnson downgraded to Neutral from Buy at UBS
    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    05/06/20 Oppenheimer
    Regeneron price target raised to $625 from $525 at Oppenheimer
    04/30/20 Roth Capital
    aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
    04/28/20 Barclays
    Sanofi price target raised to EUR 85 from EUR 80 at Barclays
    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    05/20/20 JonesTrading
    Merck collaboration positions Surface Oncology well, says JonesTrading
    04/27/20 SVB Leerink
    Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
    04/06/20 Raymond James
    NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
    03/23/20 Mizuho
    Merck business disruptions have been modest, says Mizuho
    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    03/25/20 Cantor Fitzgerald
    Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
    02/06/20 BMO Capital
    Biogen price target raised to $317 from $297 at BMO Capital
    02/05/20 Baird
    Biogen price target raised to $290 from $250 at Baird
    02/05/20 Mizuho
    Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    05/11/20 UBS
    Teva price target raised to ILS 15 from ILS 12 at UBS
    04/24/20
    Fly Intel: Top five analyst initiations
    04/24/20 Citi
    Teva initiated with a Neutral at Citi
    04/06/20 UBS
    Teva upgraded to Buy from Neutral at UBS
    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    05/18/20 Jefferies
    Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
    05/11/20 Wedbush
    MyoKardia price target raised to $127 from $90 at Wedbush
    05/11/20 UBS
    Novartis price target lowered to CHF 88 from CHF 90 at UBS
    05/06/20 Piper Sandler
    Incyte approval of Tabrecta came soon than expected, says Piper Sandler
    BAYRY Bayer
    $0.00 /

    + (+0.00%)

    04/22/20 Morgan Stanley
    Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley
    03/13/20 Goldman Sachs
    Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs
    03/11/20 Deutsche Bank
    Deutsche Bank names Bayer as 'Catalyst Call' buy idea
    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    05/21/20 Rosenblatt
    Rosenblatt sees little impact on Lumentum, NeoPhotonics' current sales to Huawei
    05/06/20 Craig-Hallum
    Lumentum price target raised to $100 from $95 at Craig-Hallum
    05/06/20 Piper Sandler
    Lumentum price target raised to $100 from $95 at Piper Sandler
    05/05/20 Raymond James
    Lumentum price target raised to $97 from $90 at Raymond James
    NPTN NeoPhotonics
    $8.31 /

    + (+0.00%)

    05/01/20 Northland
    NeoPhotonics price target raised to $13 from $9.75 at Northland
    05/01/20 Piper Sandler
    NeoPhotonics price target raised to $14 from $9 at Piper Sandler
    04/24/20 Rosenblatt
    NeoPhotonics downgraded to Neutral at Rosenblatt with stock near three-year high
    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    NPTN NeoPhotonics
    $8.31 /

    + (+0.00%)

    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    BAYRY Bayer
    $0.00 /

    + (+0.00%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    • 19
      May
    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    BAYRY Bayer
    $0.00 /

    + (+0.00%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    NPTN NeoPhotonics
    $8.31 /

    + (+0.00%)

    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    BAYRY Bayer
    $0.00 /

    + (+0.00%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    TEVA Teva
    $11.97 /

    -0.05 (-0.42%)

    SNY Sanofi
    $47.31 /

    -0.18 (-0.38%)

    NVS Novartis
    $84.84 /

    -0.12 (-0.14%)

    MYL Mylan
    $15.63 /

    -0.37 (-2.31%)

    MRNA Moderna
    $69.00 /

    +1.99 (+2.97%)

    MRK Merck
    $76.37 /

    -0.17 (-0.22%)

    LITE Lumentum
    $73.50 /

    +1.74 (+2.42%)

    JNJ Johnson & Johnson
    $144.37 /

    -0.29 (-0.20%)

    AZN AstraZeneca
    $55.21 /

    -0.04 (-0.07%)

    Hot Stocks
    KKR's Sorkin sells over 26,000 common shares » 18:04
    05/22/20
    05/22
    18:04
    05/22/20
    18:04
    KKR

    KKR

    $26.84 /

    +0.27 (+1.02%)

    In a regulatory filing,…

    In a regulatory filing, KKR general counsel and secretary David Sorkin disclosed the sale of 26,333 common shares of the company on May 20 at a price of $26.56 per share.

    ShowHide Related Items >><<
    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    05/07/20 Oppenheimer
    KKR price target lowered to $34 from $41 at Oppenheimer
    04/21/20
    Envision bankruptcy report has limited read-throughs, says Benchmark
    04/17/20 BMO Capital
    BlackRock price target raised to $441 from $386 at BMO Capital
    04/15/20 Wells Fargo
    KKR price target lowered to $33 from $38 at Wells Fargo
    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    KKR KKR
    $26.84 /

    +0.27 (+1.02%)

    Hot Stocks
    Celanese announces acetyl intermediates price increases » 18:02
    05/22/20
    05/22
    18:02
    05/22/20
    18:02
    CE

    Celanese

    $85.30 /

    -0.855 (-0.99%)

    Celanese will increase…

    Celanese will increase list and off-list selling prices for the following acetyl intermediates products: acetic acid, vinyl acetate monomer, acetic anhydride, and vinyl-based emulsions. The price increases are for orders shipped and will be effective immediately, or as contracts otherwise allow, and are incremental to any previously announced increases.

    ShowHide Related Items >><<
    CE Celanese
    $85.30 /

    -0.855 (-0.99%)

    CE Celanese
    $85.30 /

    -0.855 (-0.99%)

    05/18/20 Deutsche Bank
    Celanese Q2 tracking better than expected, says Deutsche Bank
    04/29/20 SunTrust
    Celanese price target lowered to $85 from $110 at SunTrust
    04/29/20 Wells Fargo
    Celanese downgraded to Equal Weight on 'daunting' 2020 at Wells Fargo
    04/29/20 Wells Fargo
    Celanese downgraded to Equal Weight from Overweight at Wells Fargo
    CE Celanese
    $85.30 /

    -0.855 (-0.99%)

    CE Celanese
    $85.30 /

    -0.855 (-0.99%)

    Hot Stocks
    Hertz drops over 45% as WSJ says bankruptcy filing coming as soon as Friday » 17:53
    05/22/20
    05/22
    17:53
    05/22/20
    17:53
    HTZ

    Hertz

    $2.84 /

    -0.215 (-7.04%)

    Shares of Hertz Global…

    Shares of Hertz Global (HTZ) plunged 45.8% after the Wall Street Journal reported that the company is preparing to file for bankruptcy as soon as Friday night after it failed to strike a standstill agreement with top lenders. The Journal added that the company intends to seek chapter 11 protection in the coming days after government restrictions on travel reduced air and ground traffic, hitting the vehicle rental market. The news comes two days after the Journal reported that the company, which missed debt-related payments last month, was facing a Friday deadline on negotiations with lenders and bondholders, and had asked lenders for an additional 60-day forbearance to negotiate terms.

    ShowHide Related Items >><<
    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    05/05/20 Morgan Stanley
    2020 may not be quite as bad as feared for used cars, says Morgan Stanley
    04/27/20
    Fly Intel: Top five analyst downgrades
    04/27/20 Barclays
    Barclays downgrades Hertz to Underweight on risk of capital call
    04/27/20 Barclays
    Hertz downgraded to Underweight from Equal Weight at Barclays
    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    Conference/Events
    MacroGenics to hold a pharmaceutical update conference call » 17:35
    05/22/20
    05/22
    17:35
    05/22/20
    17:35
    MGNX

    MacroGenics

    $25.35 /

    +0.2 (+0.80%)

    Management reviews MGD013…

    Management reviews MGD013 and MGC018 preliminary clinical results as presented at the 2020 Virtual Annual Meeting of ASCO on a conference call to be held on May 29 at 4:30 pm. Webcast Link

    ShowHide Related Items >><<
    MGNX MacroGenics
    $25.35 /

    +0.2 (+0.80%)

    MGNX MacroGenics
    $25.35 /

    +0.2 (+0.80%)

    05/14/20 Wedbush
    MacroGenics price target raised to $28 from $16 at Wedbush
    05/12/20 Credit Suisse
    MacroGenics price target raised to $30 from $13 at Credit Suisse
    05/06/20 H.C. Wainwright
    MacroGenics price target raised to $22 from $18 at H.C. Wainwright
    03/04/20 Barclays
    Barclays starts small, mid cap Biotechnology sector with Positive view
    MGNX MacroGenics
    $25.35 /

    +0.2 (+0.80%)

    MGNX MacroGenics
    $25.35 /

    +0.2 (+0.80%)

    Hot Stocks
    3M settles two lawsuits in Florida » 17:33
    05/22/20
    05/22
    17:33
    05/22/20
    17:33
    MMM

    3M

    $146.56 /

    +0.81 (+0.56%)

    3M has settled two…

    3M has settled two lawsuits connected with the company's global efforts to combat fraud, price gouging and counterfeiting. 3M Company and King Law Center, Chartered have resolved the legal action 3M initiated in federal district court in Orlando, Florida. The Litigation has been resolved through an agreement, and the lawsuit has been dismissed with prejudice. 3M Company and Ignite Capital Partners, Institutional Financial Sales and Auta Lopes have settled a legal action filed in Tallahassee Florida federal district court. 3M initiated the litigation. Defendants disputed and denied the claims asserted by 3M in the litigation. The parties have conferred and the litigation has been resolved. 3M and defendants share an interest in reducing fraud and/or price-gouging and have jointly cooperated to reduce such activities.

    ShowHide Related Items >><<
    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    04/29/20 Credit Suisse
    3M price target raised to $180 from $165 at Credit Suisse
    04/29/20 RBC Capital
    3M price target raised to $148 from $143 at RBC Capital
    03/30/20
    Fly Intel: Top five analyst downgrades
    03/30/20 Gordon Haskett
    3M downgraded to Underperform from Hold at Gordon Haskett
    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    MMM 3M
    $146.56 /

    +0.81 (+0.56%)

    Periodicals
    Hertz preparing bankruptcy filing as soon as Friday night, WSJ says » 17:31
    05/22/20
    05/22
    17:31
    05/22/20
    17:31
    HTZ

    Hertz

    $2.84 /

    -0.215 (-7.04%)

    Hertz Global is readying…

    Hertz Global is readying to file for bankruptcy as soon as Friday night after failing to strike a standstill deal with top lenders, the Wall Street Journal's Alexander Gladstone and Cara Lombardo report, citing people familiar with the matter. The company intends to seek chapter 11 protection in the coming days after government restrictions on travel reduced air and ground traffic, hitting the vehicle rental market, the authors note. Reference Link

    ShowHide Related Items >><<
    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    05/05/20 Morgan Stanley
    2020 may not be quite as bad as feared for used cars, says Morgan Stanley
    04/27/20
    Fly Intel: Top five analyst downgrades
    04/27/20 Barclays
    Barclays downgrades Hertz to Underweight on risk of capital call
    04/27/20 Barclays
    Hertz downgraded to Underweight from Equal Weight at Barclays
    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    HTZ Hertz
    $2.84 /

    -0.215 (-7.04%)

    Hot Stocks
    Asta Funding trading resumes  17:30
    05/22/20
    05/22
    17:30
    05/22/20
    17:30
    ASFI

    Asta Funding

    $11.40 /

    +0.04 (+0.35%)

     
    ShowHide Related Items >><<
    ASFI Asta Funding
    $11.40 /

    +0.04 (+0.35%)

    Hot Stocks
    Grupo Simec receives noncompliance notice from NYSE » 17:29
    05/22/20
    05/22
    17:29
    05/22/20
    17:29
    SIM

    Grupo Simec

    $6.85 /

    +0.8 (+13.22%)

    Grupo Simec announced…

    Grupo Simec announced that on May 18, 2020, as a result of its failure to timely file with the Securities and Exchange Commission its Annual Report on Form 20-F for the fiscal year ended December 31, 2019, it received a notice from the NYSE American LLC stating that the Company is not in compliance with the NYSE continued listing standards. The letter from the NYSE also notes that, as a result, the Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide. As previously disclosed by the Company in its Form 12b-25 filed with the SEC on May 1, 2020, the Company was unable to file its Form 20-F by its original deadline without unreasonable effort or expense due to the fact that the Company's preparation of the financial information in the annual report for inclusion in Form 20-F has not been completed due to the overall delay in operations caused by the COVID-19 pandemic. The Company is still working to complete certain disclosure regarding the financial information in the Form 20-F and expects that it will file the Form 20-F by August 15, 2020. However, the timing of the filing is uncertain at this moment, and this projected filing date could change. The NYSE informed the Company that, under the Exchange rules, the Company will have six months from May 18, 2020, to file the Form 20-F with the SEC in order to cure the noncompliance.

    ShowHide Related Items >><<
    SIM Grupo Simec
    $6.85 /

    +0.8 (+13.22%)

    SIM Grupo Simec
    $6.85 /

    +0.8 (+13.22%)

    Syndicate
    InVivo Therapeutics files to sell 1.83M shares of common stock for holders  17:27
    05/22/20
    05/22
    17:27
    05/22/20
    17:27
    NVIV

    InVivo Therapeutics

    $1.55 /

    -0.08 (-4.91%)

     
    ShowHide Related Items >><<
    NVIV InVivo Therapeutics
    $1.55 /

    -0.08 (-4.91%)

    Conference/Events
    Alamos Gold to host conference call » 17:23
    05/22/20
    05/22
    17:23
    05/22/20
    17:23
    AGI

    Alamos Gold

    $8.24 /

    -0.025 (-0.30%)

    Investor conference call…

    Investor conference call to be held on May 28 at 4:05 pm. Webcast Link

    ShowHide Related Items >><<
    AGI Alamos Gold
    $8.24 /

    -0.025 (-0.30%)

    AGI Alamos Gold
    $8.24 /

    -0.025 (-0.30%)

    05/01/20 TD Securities
    Alamos Gold price target raised to C$17 from C$16.50 at TD Securities
    05/01/20 BMO Capital
    BMO backs Outperform on Alamos Gold after Q1 results
    04/23/20 National Bank
    Alamos Gold upgraded to Outperform from Sector Perform at National Bank
    03/12/20 BofA
    Alamos Gold downgraded to Underperform from Neutral at BofA
    AGI Alamos Gold
    $8.24 /

    -0.025 (-0.30%)

    Hot Stocks
    SolarWinds CFO sells 95.4K shares of common stock » 17:18
    05/22/20
    05/22
    17:18
    05/22/20
    17:18
    SWI

    SolarWinds

    $18.05 /

    +0.38 (+2.15%)

    In a regulatory filing,…

    In a regulatory filing, SolarWinds disclosed that its CFO James Kalsu sold 95.4K shares of common stock on May 21st. The total transaction size was $1.7M.

    ShowHide Related Items >><<
    SWI SolarWinds
    $18.05 /

    +0.38 (+2.15%)

    SWI SolarWinds
    $18.05 /

    +0.38 (+2.15%)

    04/23/20 Credit Suisse
    SolarWinds downgraded to Neutral from Outperform at Credit Suisse
    02/05/20 Jefferies
    SolarWinds should be bought on earnings selloff, says Jefferies
    01/10/20 Barclays
    SolarWinds downgraded to Underweight on competitive headwinds at Barclays
    01/10/20 Barclays
    SolarWinds downgraded to Underweight from Equal Weight at Barclays
    SWI SolarWinds
    $18.05 /

    +0.38 (+2.15%)

    Conference/Events
    Microsoft participates in a conference call with Piper Sandler » 17:16
    05/22/20
    05/22
    17:16
    05/22/20
    17:16
    MSFT

    Microsoft

    $183.58 /

    +0.13 (+0.07%)

    Conference call with Doug…

    Conference call with Doug burger, Technical Fellow of Microsoft Azure Hardware, will be held on May 26 at 11 am hosted by Piper Sandler. Webcast Link

    ShowHide Related Items >><<
    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    05/18/20 RBC Capital
    Microsoft price target raised to $200 from $196 at RBC Capital
    05/15/20 Morgan Stanley
    Security another large market opportunity for Microsoft, says Morgan Stanley
    05/06/20 Craig-Hallum
    MicroVision rise driven by Microsoft speculation, says Craig-Hallum
    04/30/20 Credit Suisse
    Microsoft price target raised to $195 from $190 at Credit Suisse
    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    MSFT Microsoft
    $183.58 /

    +0.13 (+0.07%)

    Hot Stocks
    Adams Natural Resources board recommends shareholders reject tender offer » 17:14
    05/22/20
    05/22
    17:14
    05/22/20
    17:14
    PEO

    Adams Natural Resources

    $10.94 /

    +0.06 (+0.55%)

    The board of Adams…

    The board of Adams Natural Resources Fund unanimously recommends that shareholders reject the tender offer made by activists Bulldog Investors, LLC and Ancora Advisors, LLC because it furthers a damaging short-term agenda that enriches the Group at the expense of longer-term shareholders. The Board believes the Group has made the Offer with one goal in mind - to gain control of the Fund and liquidate it for personal profit. The board believes they are short-term opportunists who bought shares with the express intent to do this, and are not "investors" interested in the well-being of the 90-year-old Fund's long-term shareholders.

    ShowHide Related Items >><<
    PEO Adams Natural Resources
    $10.94 /

    +0.06 (+0.55%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.